Studies on osteoporosis VII. Effect of 17 beta-hydroxy-4-estren-3-one 17-decanoate on experimental osteoporosis

Steroids. 1982 Aug;40(2):125-32. doi: 10.1016/0039-128x(82)90026-5.

Abstract

Total body neutron activation analysis was employed to measure total calcium in C3H/St (Ha) female mice. Ninety-nine percent of total body calcium is in bone and loss of calcium was used as an index of osteoporosis. Heparin (500 U/kg B.I.D.) treatment for three months resulted in significant osteoporosis. 17 beta-Hydroxy-4-estren-3-one 17-decanoate 1.5 mg/kg or 4 mg/kg twice monthly prevented this heparin accelerated osteoporosis. The results suggest that 17 beta-hydroxy-4-estren-3-one 17-decanoate may be capable of preventing bone loss and partially increasing bone mass in patients exposed to osteoporosis inducing regimens.

MeSH terms

  • Animals
  • Bone and Bones / metabolism
  • Calcium / metabolism
  • Female
  • Heparin / therapeutic use
  • Mice
  • Mice, Inbred C3H
  • Nandrolone / analogs & derivatives*
  • Nandrolone / therapeutic use
  • Nandrolone Decanoate
  • Neutron Activation Analysis
  • Osteoporosis / prevention & control*

Substances

  • Nandrolone
  • Heparin
  • Nandrolone Decanoate
  • Calcium